Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Radiometer’s POC Analyzers Help to Evolve Pathology Services in Cornwall

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
The ABL800, ABL90 and AQT90 FLEX helps to meet diagnostic testing demands in remote locations.

Radiometer’s range of point-of-care (POC) analyzers - the ABL800 FLEX, the ABL90 FLEX and the AQT90 FLEX - have helped pathology services at the Royal Cornwall Hospitals Trust to meet diagnostic testing demands in remote locations.

Louise Silver, Nurse Practitioner and Manager of the Urgent Care Centre (UCC) at the West Cornwall Hospital, Penzance, explained: “The UCC provides ‘middle ground’ emergency care for patients with minor injuries and acute illnesses, with more serious cases being referred to the main Trust site at Treliske Hospital in Truro. Geographically, Penzance is quite isolated - it is 28 miles from Treliske - and it is important to be able to offer an intermediate triage service. POC testing gives us fast turnaround times, helping to speed up patient care without having to wait for results to arrive from the pathology laboratory in Truro.”

Helen Hobba, Senior Biomedical Scientist and lead in point of care for Biochemistry at Treliske Hospital, continued: “As well as the POC analyzers, we have Radiometer’s AQURE software. This provides the laboratory with a really useful remote link to the instruments, allowing us to monitor the analyzers and, if necessary, troubleshoot from a distance, which saves a great deal of time. We can see the status of the instrument and offer advice to users over the phone, which is particularly useful when assistance is needed at Penzance, saving both time and money.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Radiometer Acquires HemoCue
The acquisition brings together two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.
Tuesday, June 10, 2014
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos